Statement by PAHO/WHO Investigation of Serious Adverse Events in Peru - Vol. 5, No.10.(27 March 2008)
|
This PAHO/WHO statement provides results of the investigation of serious adverse events that occurred in October 2007 in Peru following administration of the yellow fever vaccine (substrain 17DD) manufactured by Bio-Manguinhos, Brazil. |